We are live on
!
Find out more
PAMP
Polar Asset Management Partners Portfolio holdings
AUM
$5.01B
1-Year Est. Return
35.02%
This Fund
S&P 500
This Quarter
Est. Return
+10.85%
1 Year Est. Return
+35.02%
3 Year Est. Return
+91.93%
5 Year Est. Return
+123.34%
10 Year Est. Return
+317%
AUM
$6.4B
AUM Growth
+$2.06B
(+48%)
Cap. Flow
+$648M
Cap. Flow
% of AUM
10.12%
Top 10 Holdings %
Top 10 Hldgs %
51.24%
Holding
786
New
253
Increased
68
Reduced
91
Closed
184
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sprott Physical Gold
PHYS
|
+$301M |
| 2 |
SKX
Skechers
SKX
|
+$96.7M |
| 3 |
AZEK
The AZEK Co
AZEK
|
+$42.1M |
| 4 |
AVDX
AvidXchange
AVDX
|
+$33.9M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
+$27.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$42.7M |
| 2 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$39.2M |
| 3 |
DESP
Despegar.com
DESP
|
+$37.4M |
| 4 |
Insulet
PODD
|
+$34.6M |
| 5 |
JWN
Nordstrom
JWN
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.29% |
| 2 | Technology | 7.51% |
| 3 | Healthcare | 5.9% |
| 4 | Consumer Discretionary | 4.16% |
| 5 | Communication Services | 3.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATMC
301
DELISTED
AlphaTime Acquisition Corp
ATMC
| $1.77M | 0.03% |
150,000
| – | – |
|
302
Nurix Therapeutics
NRIX
$2.65B
| $1.76M | 0.03% |
+154,400
| New | +$1.67M |
|
|
CHPG
303
ChampionsGate Acquisition Corp
CHPG
| $1.75M | 0.03% |
+175,000
| New | +$1.75M |
|
|
KVAC
304
DELISTED
Keen Vision Acquisition Corp
KVAC
| $1.71M | 0.03% |
150,000
| – | – |
|
305
Workiva
WK
$3.54B
| $1.7M | 0.03% |
24,771
-60,604
| -71% | -$4.17M |
|
306
Cohen & Steers Tax-Advantaged Preferred Securities & Income Fund
PTA
$1.05B
| $1.66M | 0.03% |
+83,650
| New | +$1.6M |
|
|
STAI
307
DELISTED
ScanTech AI Systems
STAI
| $1.66M | 0.03% |
150,000
+75,000
| +100% | +$1.85M |
|
|
CFLT
308
DELISTED
Confluent
CFLT
| $1.61M | 0.03% |
+64,500
| New | +$1.45M |
|
309
Celestica
CLS
$36.5B
| $1.57M | 0.02% |
10,000
-5,000
| -33% | -$531K |
|
|
LPAA
310
Launch One Acquisition Corp
LPAA
$81.4M
| $1.56M | 0.02% |
150,000
| – | – |
|
311
IAMGOLD
IAG
$10.5B
| $1.56M | 0.02% |
212,000
-38,000
| -15% | -$266K |
|
312
Capri Holdings
CPRI
$1.74B
| $1.56M | 0.02% |
+88,100
| New | +$1.45M |
|
313
WIX.com
WIX
$2.52B
| $1.51M | 0.02% |
+9,500
| New | +$1.53M |
|
314
CALL
Hims & Hers Health
HIMS
$7.31B
| $1.5M | 0.02% |
+30,000
| New | +$1.36M |
|
|
CWAN
315
DELISTED
Clearwater Analytics
CWAN
| $1.48M | 0.02% |
+67,700
| New | +$1.56M |
|
|
PEO
316
Adams Natural Resources Fund
PEO
$725M
| $1.44M | 0.02% |
+67,184
| New | +$1.38M |
|
317
Lantheus
LNTH
$6.59B
| $1.42M | 0.02% |
17,399
-17,269
| -50% | -$1.52M |
|
318
Repligen
RGEN
$9.25B
| $1.42M | 0.02% |
11,400
+9,082
| +392% | +$1.16M |
|
319
Telesat
TSAT
$897M
| $1.41M | 0.02% |
+57,500
| New | +$1.01M |
|
320
West Pharmaceutical
WST
$24.9B
| $1.29M | 0.02% |
5,901
-47,169
| -89% | -$10.1M |
|
|
NVO
321
Novo Nordisk
NVO
$209B
| $1.28M | 0.02% |
+18,600
| New | +$1.27M |
|
322
West Fraser Timber
WFG
$5.65B
| $1.28M | 0.02% |
+17,500
| New | +$1.3M |
|
323
Denali Therapeutics
DNLI
$3.97B
| $1.28M | 0.02% |
91,600
+70,648
| +337% | +$994K |
|
|
KDKRW
324
Kodiak AI Warrants
KDKRW
| $1.26M | 0.02% |
1,150,000
-100,000
| -8% | -$85.8K |
|
325
CALL
Amprius Technologies
AMPX
$1.73B
| $1.26M | 0.02% |
+300,000
| New | +$844K |
|
Similar funds
SGM
AM
MA
NL
SNT
BCM
O
FFB
Polar Asset Management Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Polar Asset Management Partners held 786 positions worth $6.4B, up 48% from $4.34B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Polar Asset Management Partners deployed $648M of net new capital in Q2 2025, opening 253 new positions and adding to 68 existing holdings. Its largest new stake was Skechers: 1,684,545 shares worth $106M.
By sector, the portfolio is most concentrated in Financials at 8.3% of assets, down from 11% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Insulet, an estimated $34.6M trimmed.
- Polar Asset Management Partners's largest Q2 2025 buy was Skechers: 1,684,545 shares worth $106M.
- Polar Asset Management Partners added most to Sprott Physical Gold in Q2 2025, an estimated $301M increase.
- Polar Asset Management Partners's biggest Q2 2025 reduction was Insulet, cutting an estimated $34.6M.
- Polar Asset Management Partners fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $42.7M.
- Polar Asset Management Partners's ten largest holdings make up 51% of its $6.4B portfolio in Q2 2025.
- Polar Asset Management Partners opened 253 new positions and closed 184 in Q2 2025.
- Polar Asset Management Partners's portfolio value rose 48% quarter-over-quarter to $6.4B.
Based on Polar Asset Management Partners's 13F filing for Q2 2025, filed 14 Aug 2025.